| Dr Mark Owen Moleski, MD | |
|
791 Kenmoor Se, Suite A Cascade Ophthalmology Pc, Grand Rapids, MI 49546-8625 | |
| (616) 575-8200 | |
| (616) 954-9622 |
| Full Name | Dr Mark Owen Moleski |
|---|---|
| Gender | Male |
| Speciality | Ophthalmology |
| Location | 791 Kenmoor Se, Grand Rapids, Michigan |
| Accepts Medicare Assignments | Does not participate in Medicare Program. He may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1033102371 | NPI | - | NPPES |
| 0358470002 | Other | DMERC | |
| 2116382 | Medicaid | MI | |
| 180410703 | Other | MI | BLUE CROSS |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207W00000X | Ophthalmology | 4301043504 (Michigan) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Dr Mark Owen Moleski, MD 791 Kenmoor Se, Suite A, Grand Rapids, MI 49546-8625 Ph: (616) 575-8200 | Dr Mark Owen Moleski, MD 791 Kenmoor Se, Suite A Cascade Ophthalmology Pc, Grand Rapids, MI 49546-8625 Ph: (616) 575-8200 |
News Archive
Increased adoption of new digital technology has underpinned businesses' response to COVID-19, with four in ten citing it as both vital to retaining jobs, and the ongoing viability of their business model, according to a new report from the University of Liverpool.
According to a study published today by a Finnish-English research group, a switch from 5-yearly screen intervals to individualized intervals could annually prevent 8% of myocardial infarcts and strokes without increasing health care costs.
Botox- (onabotulinum toxin-A) injections to the bladder are as effective as medication for treating urinary urgency incontinence in women, but the injection is twice as likely to completely resolve symptoms. These findings were published in the latest issue of The New England Journal of Medicine by a National Institutes of Health clinical trials network including Loyola University Chicago Stritch School of Medicine (SSOM).
MIT chemical engineers have developed a new sensor that lets them see inside cancer cells and determine whether the cells are responding to a particular type of chemotherapy drug.
Sorin Group, a global medical device company and a leader in the treatment of cardiovascular diseases, today announced the Canadian approval of its Perceval sutureless aortic valve.
› Verified 3 days ago
Dr. Laura J Piippo, M.D. Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 750 E Beltline Ave Ne, Grand Rapids, MI 49525 Phone: 616-949-2600 Fax: 616-365-2076 | |
Melissa Lynn Meldrum, M.D. Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 2757 Leonard St Ne, Suite 300, Grand Rapids, MI 49525 Phone: 616-942-6687 Fax: 616-942-9797 | |
Dr. Robert J Roosenberg, M.D. Ophthalmology Medicare: Not Enrolled in Medicare Practice Location: 750 E Beltline Ave Ne, Grand Rapids, MI 49525 Phone: 616-949-2600 Fax: 616-365-2076 | |
Greg Bever, M.D. Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 5030 Cascade Rd Se, Grand Rapids, MI 49546 Phone: 616-954-2020 | |
Dr. Mark E Sheldon, MD Ophthalmology Medicare: Not Enrolled in Medicare Practice Location: 750 E Beltline Ave Ne, Grand Rapids, MI 49525 Phone: 616-949-2600 Fax: 616-365-2076 | |
Dr. Tiffany Lauren Kent, MD, PHD Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 4070 Lake Dr Se, Suite 205, Grand Rapids, MI 49546 Phone: 616-888-2948 Fax: 616-888-2949 |